Home > Insider Trading > Filing (0001181431-13-026204)

Filing Details

Accession Number:: 0001181431-13-026204
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-05-08 16:10:51
Reporting Period:: 2013-05-02

Filing Date:: 2013-05-08
Accepted Time:: 2013-05-08 16:10:51
Original Submission Date:: 2013-05-06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1108205	Curis Inc	CRIS	Biological Products, (No Disgnostic Substances) (2836)	043505116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190121	R Daniel Passeri	4 Maguire Road Lexington MA 02421	Ceo And Director	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-05-02	50,000	$2.43	200,750	No	4	M	Direct
Common Stock	Disposition	2013-05-02	50,000	$3.66	150,750	No	4	S	Direct
Common Stock	Acquisiton	2013-05-03	65,000	$2.43	215,750	No	4	M	Direct
Common Stock	Disposition	2013-05-03	65,000	$3.73	150,750	No	4	S	Direct
Common Stock	Acquisiton	2013-05-06	60,000	$2.43	210,750	No	4	M	Direct
Common Stock	Disposition	2013-05-06	60,000	$3.66	150,750	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified stock option	Disposition	2013-05-02	50,000	$0.00	60,000	$2.43
Common Stock	Non-qualified stock option	Disposition	2013-05-03	65,000	$0.00	65,000	$2.43
Common Stock	Non-qualified stock option	Disposition	2013-05-06	60,000	$0.00	60,000	$2.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
348,785	2007-05-13	2013-05-13	No	4	M	Direct
283,785	2007-05-13	2013-05-13	No	4	M	Direct
223,785	2007-05-13	2013-05-13	No	4	M	Direct

Footnotes

The Form 4 filed on May 6, 2013 erroneously included a disposition of 262,667 shares of common stock and 135,000 shares of common stock on May 6, 2013. This Form 4/A is intended to amend such entries and to provide for the proper transaction which entailed an acquisition of 60,000 shares of common stock. This Form 4/A also amends the number of securities beneficially owned following the disposition on May 6, 2013 of 60,000 shares of common stock, as such number was incorrect due to the error described above.
These shares were sold between $3.50-$3.74/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
These shares were sold between $3.70-$3.79/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
These shares were sold between $3.62-$3.74/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
Options vested over a four-year period and became fully vested on May 13, 2007.
This Form 4/A amends the entries in columns 8 and 9 of Table II of the Form 4 filed on May 6, 2013.
The Form 4 filed on May 6, 2013 erroneously included the disposition of 211,452 non-qualified stock options and 51,215 incentive stock options on May 6, 2013. This Form 4/A is intended to amend such entries and to provide for the proper transaction which entailed a disposition of 60,000 non-qualified stock options.